On this page · 9 sections
Herzuma
Generic name: trastuzumab
Brand names: Herceptin, Hercessi, Herzuma, Kanjinti, Ogivri, Ontruzant, Trazimera
What is Herzuma?
Herzuma is used in adults either by itself or with other cancer medicines to treat specific types of breast cancer or stomach cancer.
Herzuma is sometimes used when the cancer has spread to other parts of the body (metastatic).
Herzuma may also be used for reasons not mentioned in this medication guide.
This section was rewritten for readability and reviewed for meaning.
Warnings
Do not use if you are pregnant. Use effective birth control.
Herzuma can cause serious side effects, including infusion reactions and life-threatening heart and lung problems. Tell your doctor if you experience symptoms such as a new or worsening cough, dizziness, headaches, chest pain, trouble breathing, swelling, or rapid weight gain.
This section was rewritten for readability and reviewed for meaning.
Before taking this medicine
Tell your doctor if you have or have ever had:
- heart problems such as a heart attack, congestive heart failure, high blood pressure, and heart rhythm disorder;
- chemotherapy; or
- lung or breathing problems.
This medicine may cause birth defects or death to the unborn baby. Do not use if you are pregnant. You may need to take a pregnancy test before starting this treatment. Use effective birth control while receiving Herzuma and for at least 7 months after your last dose. Tell your doctor if you become pregnant or think you may be pregnant.
It may not be safe to breastfeed while using this medicine and for at least 7 months after your last dose. Ask your doctor about the risk.
This section was rewritten for readability and reviewed for meaning.
Herzuma side effects
Get emergency medical help if you have signs of an allergic reaction: hives, difficulty breathing, swelling of your face, lips, tongue, or throat.
Some side effects may occur during or within 24 hours of receiving this injection and may lead to serious lung problems. Tell your medical caregiver if you feel dizzy, nauseous, light-headed, itchy, sweaty, or have a headache, chest tightness, back pain, trouble breathing, or swelling in your face.
Tell your medical caregivers right away if you have:
- a feeling that you might faint;
- severe headache, blurred vision, pounding in your neck or ears;
- heart problems—pounding heartbeats, dizziness, loss of consciousness, swelling, cough, rapid weight gain (more than 5 pounds in 24 hours), new or worsening shortness of breath; or
- low blood cell counts—fever, chills, tiredness, mouth sores, skin sores, sore throat, easy bruising, unusual bleeding, pale skin, cold hands and feet, feeling light-headed.
Your cancer treatments may be delayed or permanently stopped if you have certain side effects.
Common side effects of Herzuma may include:
- heart problems;
- nausea, diarrhea, weight loss;
- headache;
- sleep problems (insomnia), feeling tired;
- low blood cell counts;
- rash;
- fever, chills, cough, or other signs of infection;
- mouth sores or irritation;
- changed sense of taste; or
- cold symptoms such as stuffy nose, sneezing, sore throat.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
This section was rewritten for readability and reviewed for meaning.
How is Herzuma given?
Your doctor will perform tests to make sure Herzuma is the right treatment for you.
Herzuma is given as an infusion into a vein. A healthcare provider will give you this injection.
Doses are based on weight. Your dose may change if you gain or lose weight.
Herzuma is usually given once every 1 or 3 weeks. Your doctor will determine how long you should receive Herzuma. Follow your doctor's dosing instructions very carefully.
You will be watched for a short time to make sure you do not have an allergic reaction or serious side effects.
You may need frequent medical tests and your cancer treatments may be delayed based on the results.
Your heart function may need to be checked before and during treatment with Herzuma. You may also need heart function testing every 6 months for 2 years after your last dose of this medicine.
You may be given other medications to help prevent serious side effects or allergic reaction. Keep taking these medicines for as long as your doctor has prescribed.
What happens if I miss a dose?
Call your doctor for instructions if you miss an appointment for your Herzuma.
This section was rewritten for readability and reviewed for meaning.
What happens if I overdose?
In a medical setting, an overdose would be treated quickly.
Follow your doctor's instructions about any limits on food, drinks, or activities.
This section was rewritten for readability and reviewed for meaning.
What other drugs will affect Herzuma?
Herzuma can have long-lasting effects on your heart, especially if you are receiving other cancer medicines. Inform your doctor about all other cancer treatments you have received and are currently receiving.
Other drugs may affect Herzuma, including prescription and over-the-counter medicines, vitamins, and herbal products. Inform your doctor about all other medicines you are using.
Biosimilar and interchangeable products are biological products that are very similar to and have no clinically meaningful differences from the reference product.
Reference products
These are biological products that have already been approved by the FDA, against which biosimilar products are compared. There is 1 for Herzuma.
Herceptin (trastuzumab) - Genentech, Inc.
| Formulation type | Strength |
|---|---|
| Multi-Dose Vial | 420 mg Discontinued |
| Single-Dose Vial | 150 mg |
View Herceptin information in detail.
Herceptin biosimilar products
Biosimilar products can only be dispensed instead of the reference product if the healthcare provider specifically prescribes the biosimilar product by name.
Pharmacy laws for biosimilar prescribing may vary by state.
Hercessi (trastuzumab-strf) - Accord BioPharma Inc.
| Formulation type | Strength |
|---|---|
| Multi-Dose Vial | 420 mg |
| Single-Dose Vial | 150 mg |
View Hercessi information in detail.
Herzuma (trastuzumab-pkrb) - CELLTRION, Inc.
| Formulation type | Strength |
|---|---|
| Multi-Dose Vial | 420 mg |
| Single-Dose Vial | 150 mg |
Kanjinti (trastuzumab-anns) - Amgen Inc.
| Formulation type | Strength |
|---|---|
| Multi-Dose Vial | 420 mg |
| Single-Dose Vial | 150 mg |
View Kanjinti information in detail.
Ogivri (trastuzumab-dkst) - Biocon Biologics Inc.
| Formulation type | Strength |
|---|---|
| Multi-Dose Vial | 420 mg |
| Single-Dose Vial | 150 mg |
View Ogivri information in detail.
Ontruzant (trastuzumab-dttb) - Samsung Bioepis Co., Ltd.
| Formulation type | Strength |
|---|---|
| Multi-Dose Vial | 420 mg |
| Single-Dose Vial | 150 mg |
View Ontruzant information in detail.
Trazimera (trastuzumab-qyyp) - Pfizer Ireland Pharmaceuticals Unlimited Company
| Formulation type | Strength |
|---|---|
| Multi-Dose Vial | 150 mg |
| Multi-Dose Vial | 420 mg |
View Trazimera information in detail.
This section was rewritten for readability and reviewed for meaning.
Common questions about Herzuma
Biosimilars vs Biologics: What are they and how do they compare?
What are the biosimilars of Herceptin?
How soon can you start chemo after port placement?
How long can you stay on Herceptin and Perjeta?
What happens after Herceptin treatment?
How long can I stay on Herceptin?
What is TDM1 chemotherapy?
Related medicines
Content is provided for education and is not medical advice. See our medical disclaimer.